U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse announces the availability of funding for implementation of the Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01) Grant. The purpose of this grant is to identify chromosomal loci and/or genetic variation and haplotypes that are associated with either increased or decreased vulnerability to drug addiction, including stimulants (e.g. cocaine, amphetamine, caffeine), narcotics (e.g. opiates), nicotine/tobacco products, benzodiazepines, barbiturates, cannabis, hallucinogens, and/or multiple drugs of abuse and, as needed, accounting for associated co . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | December 10, 2013

Federal Government Announces Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01) Grant Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member